Combining tradition with modernity:
Bayer hones its brand profile
Leverkusen, April 4, 2018 – Dynamic, open, personal: From today forward, these attributes will be
the new public face of the Bayer brand. As CEO Werner Baumann
explained: “Our brand is our most important distinguishing feature.
People from all over the world have been placing their trust in Bayer
for more than 150 years.” The new brand thus reconciles Bayer’s long
heritage with the challenges facing a large, multinational company in
today’s digital world especially. With the company’s focus on health and
nutrition, it was time to reflect these changes in Bayer’s brand.
The evolution of Bayer’s brand is evident in all
areas: in online and offline visual and audiovisual media, in the
legendary Bayer Cross logo, and in the color scheme, photographic style
and font used. Bayer’s colors and images are now more vibrant, warm and
dynamic. Its external look is more open and cosmopolitan, and the Bayer
Cross has been carefully adapted to meet the needs of today’s digitally
connected world. At the same time, the look remains unmistakably that of
the Bayer brand – after all, the name has represented expertise and
quality the world over since 1863.
Read more about this subject in the recent blog post by Dr. Michael Preuss, head of Communications and Public Affairs at Bayer: https://www.magazine.bayer.com/en/a-strong-brand-can-t-rest-on-its-laurels.aspx
About Bayer
Bayer is a global enterprise with core competencies
in the Life Science fields of health care and agriculture. Its products
and services are designed to benefit people and improve their quality of
life. At the same time, the Group aims to create value through
innovation, growth and high earning power. Bayer is committed to the
principles of sustainable development and to its social and ethical
responsibilities as a corporate citizen. In fiscal 2017, the Group
employed around 99,800 people and had sales of EUR 35.0 billion. Capital
expenditures amounted to EUR 2.4 billion, R&D expenses to EUR 4.5
billion. For more information, go to www.bayer.com.
Forward-Looking Statements
This release may contain
forward-looking statements based on current assumptions and forecasts
made by Bayer management. Various known and unknown risks, uncertainties
and other factors could lead to material differences between the actual
future results, financial situation, development or performance of the
company and the estimates given here. These factors include those
discussed in Bayer’s public reports which are available on the Bayer
website at www.bayer.com.
The company assumes no liability whatsoever to update these
forward-looking statements or to conform them to future events or
developments.